The PE Ratio as of December 2025 (TTM) for Cara Therapeutics, Inc. (0HTC.L) is -8.88

According to Cara Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -8.88. This represents a change of 369.67% compared to the average of -1.89 of the last 4 quarters.

Cara Therapeutics, Inc. (0HTC.L) Historical PE Ratio (quarterly & annually)

How has 0HTC.L PE Ratio performed in the past?

The mean historical PE Ratio of Cara Therapeutics, Inc. over the last ten years is -0.86. The current -8.88 PE Ratio has changed 103.43% with respect to the historical average. Over the past ten years (40 quarters), 0HTC.L's PE Ratio was at its highest in in the June 2025 quarter at 11.54. The PE Ratio was at its lowest in in the September 2025 quarter at -16.53.

Cara Therapeutics, Inc. (0HTC.L) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cara Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cara Therapeutics, Inc. (0HTC.L) Average PE Ratio

How has 0HTC.L PE Ratio performed in the past?

The current PE Ratio of Cara Therapeutics, Inc. (0HTC.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Cara Therapeutics, Inc. (0HTC.L) PE Ratio vs. Peers

How is 0HTC.L’s PE Ratio compared to its peers?

Cara Therapeutics, Inc.’s PE Ratio is less than VivoSim Labs, Inc. (-2.67), less than Imunon, Inc. (-0.00), less than Palatin Technologies, Inc. (-5.66), less than Unity Biotechnology, Inc. (-0.12), less than Endo International plc (-0.00), less than DMK Pharmaceuticals Corporation (-0.00), less than bluebird bio, Inc. (-0.24), less than Zynerba Pharmaceuticals, Inc. (-1.59), less than Accelerate Diagnostics, Inc. (-0.02), less than Invitae Corporation (-0.00),

Build a custom stock screener for Cara Therapeutics, Inc. (0HTC.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cara Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cara Therapeutics, Inc. (0HTC.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cara Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.